MSA will be attending Future Pharma 2018: Connecting Marketing and Sales in the Digital Age, September 26-28, in Boston. Tony Fontecchio, VP, Life Sciences, and Steve Gongaware, SVP, are excited to meet with pharmaceutical marketing and sales executives to discuss the value of integrating their patient-level data with MSA data.
MSA Life Sciences’ Healthcare Data Management provides a single platform for sourcing, securing, integrating, and sharing data. Having a common platform gives pharmaceutical manufacturers a competitive advantage by enabling them to simplify operations, improve data quality and analytic value, and demonstrate value to stakeholders.
For decades, MSA has been a leading third party provider of data de-identification and data integration solutions that provide unique insights at the patient level. Bringing together MSA Lab, EMR, and Claims data with customer patient-level data, MSA HCDM creates a de-identified, longitudinally-aligned data set that is ready for MSA and/or the customer’s sophisticated analytics to support use cases, such as:
• Physician Targeting and Sales Force Allocation
• Patient Outcomes and Treatment Effectiveness Monitoring
• Brand Utilization and Performance Measurement
• Pharmacy Network Performance Evaluation
For more information and/or to reserve a time to meet with Tony and Steve at the Future Pharma 2018 conference, please visit http://hcdm.msa.com.